Fluconazole Iv Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) solution
Available Strengths: 2 mg/mL (or higher concentrations)
Reference Brands: Diflucan IV(US & EU)
Category:
Anti-fungal
Fluconazole IV inhibits fungal cell membrane synthesis by blocking the enzyme lanosterol 14α-demethylase. It effectively treats systemic fungal infections, offering benefits like rapid absorption, excellent tissue penetration, broad-spectrum antifungal activity, and a favorable safety profile, making it vital for managing severe fungal infections in hospitalized patients.
Fluconazole IV is available in Intravenous (IV) solution
and strengths such as 2 mg/mL (or higher concentrations).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluconazole IV is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluconazole IV can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluconazole IV is an antifungal approved in the EU and US for severe fungal infections. In the EU, Pfizer’s Diflucan IV and generics are regulated by EMA, supported by dossiers demonstrating quality, safety, and efficacy. In the US, the FDA approved Diflucan IV and biosimilars based on comprehensive clinical data and biosimilarity assessments, with continuous pharmacovigilance. Both regions require detailed dossiers for approval and post-marketing safety monitoring. For expert support with pharmaceutical dossiers and regulatory compliance, visit PharmaTradz, your trusted partner in regulatory solutions, ensuring smooth approval and market access for fluconazole IV formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing